A detailed history of Ashton Thomas Securities, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 2,082 shares of ABBV stock, worth $401,555. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,082
Previous 1,942 7.21%
Holding current value
$401,555
Previous $384 Million 4.41%
% of portfolio
0.1%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$164.99 - $203.87 $23,098 - $28,541
140 Added 7.21%
2,082 $367 Million
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $56,360 - $68,569
344 Added 21.53%
1,942 $384 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $247,354 - $288,854
1,598 New
1,598 $269 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ashton Thomas Securities, LLC Portfolio

Follow Ashton Thomas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Securities, LLC with notifications on news.